These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20107148)

  • 21. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
    Currò D; Ianiro G; Pecere S; Bibbò S; Cammarota G
    Br J Pharmacol; 2017 Jun; 174(11):1426-1449. PubMed ID: 27696378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of VSL#3 Probiotic in a Patient with Glycogen Storage Disease Type Ia and Irritable Bowel Disease-like Disease.
    Carnero-Gregorio M; Molares-Vila A; Corbalán-Rivas A; Villaverde-Taboada C; Rodríguez-Cerdeira C
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):143-149. PubMed ID: 29441457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
    Cash BD
    Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irritable bowel syndrome and probiotics: from rationale to clinical use.
    Verdu EF; Collins SM
    Curr Opin Gastroenterol; 2005 Nov; 21(6):697-701. PubMed ID: 16220048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
    Jonkers D; Penders J; Masclee A; Pierik M
    Drugs; 2012 Apr; 72(6):803-23. PubMed ID: 22512365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
    Jakubczyk D; Leszczyńska K; Górska S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applications of probiotics in gastrointestinal disorders in children.
    Chen CC; Walker WA
    Natl Med J India; 2011; 24(3):153-60. PubMed ID: 21786845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the role of probiotics in gastrointestinal diseases in adults.
    Sebastián Domingo JJ
    Gastroenterol Hepatol; 2017; 40(6):417-429. PubMed ID: 28185664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics: do they help to control intestinal inflammation?
    Böhm SK; Kruis W
    Ann N Y Acad Sci; 2006 Aug; 1072():339-50. PubMed ID: 17057214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.
    Bonavina L; Arini A; Ficano L; Iannuzziello D; Pasquale L; Aragona SE; Ciprandi G; On Digestive Disorders ISG
    Acta Biomed; 2019 Jul; 90(7-S):8-12. PubMed ID: 31292420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics--role in inflammatory bowel disease.
    Gionchetti P; Amadini C; Rizzello F; Venturi A; Palmonari V; Morselli C; Romagnoli R; Campieri M
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S58-62. PubMed ID: 12408442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials.
    Fujiya M; Ueno N; Kohgo Y
    Clin J Gastroenterol; 2014 Feb; 7(1):1-13. PubMed ID: 26183502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of probiotics in prevention and therapy].
    Deibert P; König D; Becker G; Berg A
    Dtsch Med Wochenschr; 2010 Feb; 135(8):345-9. PubMed ID: 20165999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis.
    Dong J; Teng G; Wei T; Gao W; Wang H
    PLoS One; 2016; 11(12):e0168785. PubMed ID: 28005973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review.
    Dale HF; Rasmussen SH; Asiller ÖÖ; Lied GA
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31480656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.
    Shen J; Zuo ZX; Mao AP
    Inflamm Bowel Dis; 2014 Jan; 20(1):21-35. PubMed ID: 24280877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.